U.S. regulators have approved updated COVID-19 vaccines from Pfizer and Moderna, shots aimed at revving up protection this fall and winter
WASHINGTON — — The U.S. approved updated COVID-19 vaccines Monday, hoping to rev up protection against the latest coronavirus strains and blunt any surge this fall and winter.from Moderna and Pfizer and its partner BioNTech to most Americans even if they've never had a coronavirus vaccination. It's part of a shift to treat fall updates of the COVID-19 vaccine much like getting a yearly flu shot.
COVID-19 hospitalizations have been rising since late summer although –- thanks to some lasting immunity from prior vaccinations and infections –- not nearly as much as this time last year. Just like earlier vaccinations, the fall round is cleared for adults and children as young as age 6 months. FDA said starting at age 5, most people can get a single dose even if they’ve never had a prior COVID-19 shot. Younger children might need additional doses depending on their history of COVID-19 infections and vaccinations.
United States Latest News, United States Headlines
Similar News:You can also read news stories similar to this one that we have collected from other news sources.
FDA approves updated Covid vaccines from Pfizer and Moderna as hospitalizations riseThe Biden administration said it expects the new Pfizer and Moderna vaccines targeting the omicron variant XBB.1.5 to be available in mid-September.
Read more »
Pfizer and Moderna Covid Vaccines Approved by FDA. When They Could Become Available.This year’s rollout marks a definitive transition to a commercial market for the shots., which had previously been purchased by the U.S. government.
Read more »
Moderna ties up with Immatics to boost cancer vaccine developmentModerna said on Monday it has struck a deal with German drug developer Immatics for developing cancer vaccines and therapies, and would pay $120 million in cash and additional milestone payments.
Read more »
Stocks making the biggest moves midday: Tesla, Qualcomm, Meta, Moderna and moreThese are the stocks posting the largest moves in midday trading.
Read more »
Novak Djokovic game-winner at US Open ironically named 'Moderna Shot of the Day'Novak Djokovic won the US Open title on Sunday night, but he also received another accolade. The final play of the match was named the 'Moderna Shot of the Day.'
Read more »
Immatics shares rise on Moderna cancer collaborationImmatics NV shares gained more than 6% premarket on Monday after the company announced a collaboration with Moderna Inc. to research and develop new cancer...
Read more »